Full-Time
Enterprise Sales
Superpower
51-200 employees
Personalized functional medicine with biomarker tracking
No salary listed
H1B Sponsorship Available
San Francisco, CA, USA
In Person
 Sales & Account Management (1) |
|---|
Get referred to Superpower
See people who can refer or advise you
- At least 7 years of experience in enterprise sales with a track record of carrying and achieving a meaningful new-business quota.
- Experience selling a complex, high-consideration, long-cycle product to executive buyers and navigating procurement, security, and committee approvals.
- Ability to generate an independent pipeline without relying on leads.
- Benefits, healthcare, or human resources technology experience is strongly preferred.
- Experience understanding how benefits are purchased, the role of consultants and brokers, and the benefits calendar.
- Ability to work entrepreneurially and hands-on in an ambiguous environment.
- Own and close the enterprise pipeline, carry a quota, and achieve the target.
- Run the full sales cycle, including prospecting, discovery, navigating complex multi-stakeholder committees, and closing deals with chief human resources officers, vice presidents of total rewards, and benefits leaders.
- Adapt across deal types and geographies, taking ownership of deals assigned by fit and capacity rather than by a rigid territory.
- Partner with consultant and broker relationships connected to deals, influence strategy, and build credibility.
- Sell against the benefits calendar and drive deals to close during the relevant windows.
- Bring buyer objections, competitive signals, and pricing learnings back to leadership, Marketing, and Product.
- Help build the enterprise sales playbook as the team scales.
- Benefits, healthcare, or human resources technology experience.
Superpower specializes in functional medicine with personalized, ongoing health plans. It begins with an annual 80-biomarker blood test, and nurses collect samples in person with results tracked over a lifetime. A medical team uses the test results to design a custom health strategy that evolves as the client’s needs change, delivered through a subscription model. The goal is to make functional medicine practical and accessible, helping individuals improve and sustain health outcomes over time through tailored medical guidance.
Company Size
51-200
Company Stage
Series A
Total Funding
$47M
Headquarters
San Francisco, California
Founded
2022
Get referred to Superpower
See people who can refer or advise you
Simplify's Take
What believers are saying
- Superpower launched commercially in autumn 2025 and now has tens of thousands of members.
- IM8 partnership and Giannis Antetokounmpo endorsement expand trust and customer acquisition.
- Superpower claims 10x revenue growth over six months and over $40 million raised.
What critics are saying
- Function Health sued Superpower in January 2026 over biomarker claims and ads.
- The lawsuit threatens injunctions, corrective advertising, and damages before year-end 2026.
- Celebrity-heavy growth hides weak moat; IM8 and Function can outspend Superpower.
What makes Superpower unique
- Superpower ties annual biomarker testing directly to personalized protocols and retesting loops.
- Quest Diagnostics access and nurse home draws remove friction for consumers nationwide.
- Acquisitions of Base and Feminade broaden diagnostics beyond standard bloodwork.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Company Equity
Wellness Program
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 0%2 year growth
↓ -2%Max Marchione spent years seeing over 20 specialists as a teenager before finally getting a proper diagnosis for his sleep issues. That experience led him to found Superpower, a health super app now valued at more than $500 million. For $199 annually, members receive a blood panel testing over 100 biomarkers, an AI-generated health protocol, and access to a care team. The platform aggregates blood work, genomic data, gut microbiome testing, and wearable data into one profile, using AI to identify patterns and potential root causes. Superpower launched commercially in autumn 2025 and has attracted tens of thousands of members. Additional testing and prescriptions are billed separately. Licensed doctors handle any diagnosis or prescription needs, whilst complex cases requiring specialist care are referred externally. The 26-year-old founder previously worked at Goldman Sachs before starting Superpower.
Giannis Antetokounmpo named Global Brand Ambassador for Superpower. June 30, 2026 Deal Type: Global Brand Ambassador + Brand Investor Announced: June 30, 2026 * Giannis Antetokounmpo joins preventative health platform Superpower as a brand investor and its first-ever Global Brand Ambassador. * The deal supports Superpower's mission to make 100+ biomarker blood testing accessible at $199 a year. * Giannis's own panel flagged elevated cardiovascular risk markers and a deficient Vitamin D level, despite his elite medical team. * He joins existing Superpower partners Steve Aoki, Vanessa Hudgens, and the Winklevoss twins. Giannis Antetokounmpo is expanding his off-court portfolio into preventative healthcare. The two-time NBA MVP and 2021 champion has been named Superpower's first-ever Global Brand Ambassador, while also becoming a brand investor, the San Francisco-based company announced on June 30, 2026. Superpower offers a preventative health membership built around 100+ biomarker blood testing, aiming to close the gap between elite athlete-level care and everyday healthcare access. Even Giannis's own panel uncovered blind spots his world-class medical team had missed: elevated cardiovascular risk markers and a Vitamin D level deep in the deficient range. With his 14th NBA season approaching after recent knee and calf injuries, that kind of biomarker clarity matters for recovery and longevity. Superpower has raised over $40 million in funding, led by Forerunner Ventures, and 60% of its members have uncovered health issues their routine care overlooked. Giannis joins a roster that already includes Steve Aoki, Vanessa Hudgens, and the Winklevoss twins. This isn't Giannis's first health-and-wellness equity move. He recently became a global partner and shareholder in IM8, the David Beckham-co-founded supplement brand under Prenetics, and Superpower itself struck an integration deal with IM8 earlier this year, connecting supplementation with blood diagnostics. He's also a shareholder in delivery platform Gopuff, alongside more traditional ambassador deals with Castrol and Betano. Giannis keeps trading paychecks for ownership stakes, a pattern that signals genuine belief over marketing fees. As athletes increasingly diversify into health-tech equity, his name attached to Superpower could meaningfully boost mainstream trust in preventative testing. Does athlete equity ownership make a brand endorsement feel more credible than a paid ad deal? With Giannis now tied to Superpower, IM8, Gopuff, Castrol, and Betano, how much bandwidth can one athlete's brand really support?
Max Marchione, a University of Sydney dropout, has raised over AUD$65 million for his longevity startup Superpower, now valued at $432 million. The health "super app" has partnered with David Beckham's supplement company IM8 to create a bio-feedback loop between health measurement and solutions. Superpower's baseline test costs USD$199 annually and analyses over 100 biomarkers across 17 health categories. The company recently acquired two businesses — Feminade and Base — expanding its diagnostic capabilities. In March, it added Grail's $849 cancer screening test as an optional panel. The San Francisco-based startup claims 10x revenue growth over the past six months. Co-founded with Jacob Peter and Kevin Unkrich, Superpower faces a California lawsuit from competitor Function Health over biomarker testing marketing claims, which Marchione denies.
Prenetics Global Limited announced a strategic partnership with Superpower on 24 March 2026 to combine clinical-grade supplementation with blood diagnostics. The collaboration integrates testing and supplementation into a unified system, allowing consumers to measure supplement effectiveness through IM8 and Superpower's combined offerings. Lake Street initiated coverage on Prenetics Global with a Buy rating and $29 price target on 16 March, citing the company's transformation into a focused consumer health platform after divesting non-core assets and generating over $150 million in proceeds. Earlier in March, Prenetics authorised a $40 million share repurchase programme over 12 months. Chief Executive Officer Danny Yeung said the move reflects confidence in the business, particularly its IM8 brand, alongside strong liquidity and zero debt.
Prenetics' IM8 partners with Superpower to personalize the future of supplementation. GlobeNewswire 2 days ago 0 shares 1 views Published 2 days ago · IM8 90-Day Subscribers Unlock SuperPower Blood Testing for $49 - A 75% Saving on the Standard $199 Price. · IM8 and Superpower create the first closed-loop system in consumer health - connecting clinical-grade supplementation with 100+ biomarker blood testing. · IM8's Daily Ultimate Essentials will be available in the Superpower supplement marketplace and featured, where biomarker data supports it, as one of Superpower's recommended foundational daily supplements in members' personalized health protocols. NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) - Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading consumer health sciences company and parent of the IM8 premium health and longevity brand, today announced a strategic partnership with Superpower, the preventive health platform backed by over $40 million in venture funding. The first-of-its-kind partnership connects clinical-grade supplementation with comprehensive blood diagnostics, enabling an optimized testing loop to provide consumers with measurable proof behind supplement efficacy. IM8 and Superpower are teaming up to address a fundamental gap within the wellness industry: most people who take supplements have no way to measure whether they're working; meanwhile, most blood testing platforms surface hundreds of data points, but leave consumers to navigate a fragmented, low-quality supplement market on their own. Neither side has been able to close the gap alone - until now. Under the partnership, IM8 - co-founded by David Beckham - will integrate Superpower's annual blood testing membership into the IM8 customer journey at exclusive pricing, while Superpower will integrate IM8's Daily Ultimate Essentials into its personalized health protocols as a featured foundational nutritional ritual, available to all members on its supplement marketplace at a preferred rate. The partnership reflects a broader shift in how consumers approach their health; from reactive treatment to proactive optimization, powered by personal data. "I co-founded IM8 with David Beckham to fix the quality problem in supplements - clinical-grade formulations, full transparency, no shortcuts," said Danny Yeung, CEO of Prenetics and IM8. "But formulation was only half the equation. The other half was measurement. With Superpower, an IM8 customer can now test 100+ biomarkers, take our products for 90 days, retest, and see measurable results. That's not a marketing claim. That's proof. No other supplement brand on the market can offer that." [1] IM8 subscribers on the 90-day Daily Ultimate Essentials plan will be able to redeem a Superpower membership for $49 per year, which translates to a 75% saving on Superpower's standard $199 annual price. Monthly IM8 subscribers will gain access to the Superpower membership for $99 per year, a 50% saving. Both tiers include Superpower's complete offering: its comprehensive initial 100+ biomarker test, an AI health layer grounded in each individual's real data - not generic advice, and 24/7 access to its concierge care team. Members can upload past labs, share their health history, and get personalized insights to help them achieve their health goals. Testing is available at over 2,000 Quest Diagnostics locations nationwide, or via at-home blood draw for an additional fee. Baseline biomarker retests and additional specialty diagnostic tests are also available to members at preferred pricing. [2] "We built Superpower to move healthcare from reactive to proactive - but proactive only works when testing leads to action, and action leads back to testing," said Max Marchione, Co-Founder and CEO of Superpower. "That feedback loop has never existed in consumer health until now. IM8 gives our members a supplement protocol we can stand behind with full confidence - clinical-grade formulations built for the same standard of evidence our platform is built on. This is what the future of health looks like: data in, protocol out, results measured." IM8 ships to 31 countries and counts tennis world number one Aryna Sabalenka and Formula 1 driver Ollie Bearman among its brand ambassadors. Superpower's investors include NBA champion Giannis Antetokounmpo and the Winklevoss twins, and the platform has built the infrastructure to make preventive blood testing as routine and affordable as a gym membership. The integrated offering is available now. To learn more, IM8 customers can access Superpower membership pricing at im8health.com, and Superpower members can explore IM8's product range at superpower.com. *About Prenetics* Prenetics (NASDAQ: PRE) is a leading health sciences company dedicated to advancing human health and longevity. The Company's flagship consumer brand, IM8, co-founded with David Beckham and championed by World No. 1 tennis player Aryna Sabalenka, is redefining the premium daily nutrition category through science-backed formulations and global brand partnerships. Since its launch, IM8 has become one of the fastest-growing brands in consumer health, achieving an impressive milestone of surpassing $100 million in annualized recurring revenue within just 11 months of operations, and is now sold in more than 31 countries worldwide. *About IM8* IM8 is the pinnacle of premium core nutrition, born from a collaboration between David Beckham as a co-founding partner, and an elite team of scientists spanning medical professionals, academia and space science. Combining cutting-edge science with nature's most potent ingredients, IM8 delivers a holistic, science-backed approach to health, empowering you to live your most vibrant life. IM8's flagship product, Daily Ultimate Essentials is an all-in-one powder supplement engineered to replace 16 different supplements in a delicious drink and is NSF Certified for Sport, non-GMO, vegan, free from common allergens, and contains no artificial flavors, colors or sweeteners. IM8 is a subsidiary of Prenetics (NASDAQ: PRE), a leading global health sciences company dedicated to advancing consumer health. To learn more about IM8, please visit www.IM8health.com. *About Superpower* Superpower is a new kind of health membership - built on comprehensive lab work, not guesswork. For $199 per year, members get annual blood testing across 100+ biomarkers, an AI health layer grounded in their real data, personalized health protocols, and 24/7 concierge care. Founded by Max Marchione and Jacob Peters, Superpower has raised over $40 million in funding with its Series A led by Forerunner Ventures. Superpower is accessible at over 2,000 Quest Diagnostics locations across the US, with at-home blood draws also available. To learn more about Superpower, please visit superpower.com. *Investor Relations Contact: *[email protected] [email protected] News Page Ltd Angela Cheung Investor Relations / Corporate Finance [email protected]